Lv1
20 积分 2025-08-14 加入
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
1天前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
3天前
已完结
Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling
1个月前
已完结
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
1个月前
已完结
Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2– Early Breast Cancer Using Real-World and NATALEE Data
1个月前
已完结
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition
2个月前
已完结
Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors
2个月前
已完结
Posttreatment MRI to Predict Pathologic Complete Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
2个月前
已完结
Overview of Multimodal Radiomics and Deep Learning in the Prediction of Axillary Lymph Node Status in Breast Cancer
2个月前
已完结
XBP1s Mediates Cross-resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer
2个月前
已完结
皖公网安备34019202002308
